FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3411000001104: Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16168301000001110 Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16168401000001119 Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Is a Product containing precisely spironolactone 100 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient Spironolactone false Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Is a Spirospare true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Has specific active ingredient Spironolactone true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet Is pack of False Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet Has AMP True Spirospare 100 tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start